Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Timothy S. Kristedja et al.|Clinical Cancer Research|2023Cited by 27
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccinationEspen B. Ellingsen, Gustav Gaudernack, Eivind Hovig et al.|Journal of Translational Medicine|2022Cited by 21
Personalized <scp>HLA</scp> typing leads to the discovery of novel <scp>HLA</scp> alleles and tumor‐specific <scp>HLA</scp> variantsIrantzu Anzar, Trevor Clancy, Richard Stratford et al.|HLA|2022Cited by 16
Data from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Mohammed Milhem et al.|Unknown|2023Cited by 1
Supplementary Data 2 from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Steven O’Day et al.|Unknown|2023Cited by 0